eClinical technology company, Axiom Real-Time Metrics, will be recapitalized by Great Point Partners to provide eClinical solutions to increase service offerings for Phase I-III clinical trials.
Debbie Profit, vice president of applied innovation and process improvement at Otsuka Pharmaceuticals addressed ACRP in April and discussed the various technologies that could ‘transform’ the pharmaceutical industry.
As clinical trials create large amounts of data, and researchers seize the opportunity to use de-identified data as a means to develop and discovery, managing the information has become more and more complex.
Regeneron and UK Biobank announce human sequencing data resource for global research and to accelerate improved patient care through outcome algorithms.
Integrated research organizations aim to bridge the gap between clinical research and clinical health care with the use of RWD, yet, the data may not be ready for research, according to Elligo Data Scientist.
Parexel is adopting Medidata’s Shyft Analytics platform to bolster its real-world evidence generation and outcomes research offering to biopharmaceutical and medical device clients.
Comprehend, a clinical intelligence software company, has packaged its clinical trial risk detection and management service offerings to accommodate the needs of mid-sized CROs.
Quanticate is using CluePoints’ software to perform data integrity checks on all types of monitoring and investigator site data as part of its new Data Quality Oversight service.
The identity and access management firm Exostar has acquired UK-headquartered Pirean Limited to provide the pharma industry with simplicity, speed, and security, says VP.
LabKey and Linguamatics have designed an integrated NLP data management solution to help accelerate clinical data abstraction and curation of unstructured notes and reports for clinical research.
Harvard Medical School and Brigham Women’s Hospital have selected the Aetion Evidence Platform to further support the REPEAT program and the demand for RWE.
TransCelerate and BioCelerate have launched a new data sharing platform to connect preclinical and clinical information to help better inform clinical trials.
The FDA guidance addresses EHR data use in clinical trials – and while “one of the most prescriptive in recent memory” – does not solve interoperability challenges or address other sources of data, such as wearables.
The Alliance for Clinical Research Excellence and Safety (ACRES) has released a global quality standard for clinical research sites aimed at increasing data accuracy and integrity.
CTTI’s latest recommendations will help researchers deploy mobile technologies in clinical trials and “pave the way for improving how we develop medicines,” says Pfizer exec.
The industry needs “to strike a balance” between science and feasible execution as increasingly complex clinical trial protocols are impeding efficiency and driving up costs, says industry expert.
The industry is increasingly engaging in collaborations to gain access to technology, such as AI, which is being touted as a potential solution to some of the most challenging aspects of running clinical trials.
Japan-based ONO Pharmaceutical will use CluePoints’ centralized statistical monitoring platform to lead its RBM strategy over the next four years following a successful pilot study in 2017.
GlaxoSmithKline has selected TrialScope to facilitate clinical trial disclosure and transparency – as the benefits of patient centricity are paramount, and the risks of poor compliance magnified, says VP.
In 2018, the industry can expect risk-based everything, cloud-first strategies, and a focus on modernization as companies look to stand out amongst the competition, say Veeva Systems execs.
Clinical study database challenges are delaying clinical trial timelines as CROs and sponsors must manage an increasing variety of trial data, according to a recent study.
Global central laboratory and early development services provider, LabConnect, has launched a new data integration service to help streamline data collection and management for sponsors.
Parexel has launched an Identification of Medicinal Products (IDMP)-focused solution to help biopharmaceutical companies meet impending regulatory requirements.
Adents and Microsoft have introduced a new platform that allows contract manufacturing organizations (CMOs) to leverage data generated during the serialization process.
Using an experimental Internet of Things system that enables remote monitoring, the companies believe the multi-year project has the potential to change the way clinical trials are conducted.
CRO Covance has launched an external laboratory management service offering for biopharmaceutical sponsors looking to external lab testing for its clinical trials.
CRO Quintiles chose DIA 2011 to launch its new Infosario clinical trial data and information management system which, it says, will ‘bust’ the information silos that hamper the research process.
Perceptive Informatics, an eClinical solutions provider, has announced the results of a survey to find out what the biopharma industry considers the most important eClinical attributes.
Clinical data management is, and will continue to be a key concern for the pharmaceutical industry, according to Susan Bornstein, executive vice president of eClinical solutions, who discussed the issue with Outsourcing-pharma earlier this week.
BioClinica is providing Cephalon with end-to-end clinical data management services and hiring some of the biotech’s staff under a three-year, multi-million dollar deal.
The SCDM says that edit checks are a crucial component of achieving error-free data and has updated its Good Clinical Data Management Practices (GCDMP) resource with a best practice guide.
UK CRO Richmond Pharmacology has unveiled a new data management offering for the drug industry that it claims will help trial sponsors cut costs, save time and help guarantee data integrity.
Cognizant is gaining ground in the life sciences arena, this week
inking a $95m data management deal with AstraZeneca, just three
months after sealing another multi-million dollar deal with Merck
& Co.
